Ankylosing Spondyloarthritis

Ankylosing Spondyloarthritis is the indication for 36 drugs in DrugBank. It is covered by 40 curated, structured indications.

Also known as: Spondylitis, Ankylosing · Rheumatoid spondylitis · Ankylosing Spondylitis · Ankylosing Spondylitis (AS) · Ankylosing Spondylitis(AS)
Classified under: Immune System Diseases
Infections
Musculoskeletal and Connective Tissue Diseases
Indicated drugs: Aceclofenac
Acetaminophen
Adalimumab
Betamethasone
Bupivacaine
Celecoxib
Corticotropin
Cortisone acetate
Dexamethasone
Dexketoprofen
Diclofenac
Etanercept
Etofenamate
Etoricoxib
Flurbiprofen
Hydrocortisone
Hydrocortisone succinate
Ibuprofen
Infliximab
Ketoprofen
Meclofenamic acid
Methylprednisolone
Methylprednisolone hemisuccinate
Naproxen
Niflumic acid
and 11 more with a free account

Resolves to

Vocabularies

MeSHM0020377ICD-10M45SNOMED CT156619005MedDRA10002539UMLSC0038013

What you can answer from here — as of October 22, 2026

36Indicated drugsWith each drug's targets and mechanism

40Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

239Clinical trialsPhase, status and sponsor resolved per trial

4Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Ankylosing Spondyloarthritis share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.